Bio Gene (Australia) Price on April 27, 2023
| BGT Stock | 0.04 0 2.44% |
Below is the normalized historical share price chart for Bio Gene Technology extending back to November 29, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Bio Gene stands at 0.04, as last reported on the 11th of December 2024, with the highest price reaching 0.04 and the lowest price hitting 0.04 during the day.
If you're considering investing in Bio Stock, it is important to understand the factors that can impact its price. Bio Gene Technology secures Sharpe Ratio (or Efficiency) of -0.0219, which signifies that the company had a -0.0219% return per unit of risk over the last 3 months. Bio Gene Technology exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bio Gene's insignificant Risk Adjusted Performance, standard deviation of 4.23, and Mean Deviation of 2.41 to double-check the risk estimate we provide.
At this time, Bio Gene's Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 5 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 141.8 M in 2024. . Bio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.0538 | 50 Day MA 0.0487 | Beta 0.705 |
Bio |
Sharpe Ratio = -0.0219
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BGT |
Estimated Market Risk
| 4.29 actual daily | 38 62% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bio Gene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bio Gene by adding Bio Gene to a well-diversified portfolio.
Price Book 2.8857 | Book Value 0.014 | Enterprise Value 6 M | Enterprise Value Ebitda (2.71) | Price Sales 450.6463 |
Bio Gene Valuation on April 27, 2023
It is possible to determine the worth of Bio Gene on a given historical date. On April 27, 2023 Bio was worth 0.11 at the beginning of the trading date compared to the closed value of 0.096. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bio Gene stock. Still, in general, we apply an absolute valuation method to find Bio Gene's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bio Gene where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bio Gene's related companies.
| Open | High | Low | Close | Volume | |
| 0.1 | 0.1 | 0.09 | 0.1 | 551,116 | |
04/27/2023 | 0.11 | 0.11 | 0.1 | 0.1 | 41,386 |
| 0.11 | 0.11 | 0.11 | 0.11 | 82,510 |
| Backtest Bio Gene | | | Bio Gene History | | | Bio Gene Valuation | Previous | Next |
Bio Gene Trading Date Momentum on April 27, 2023
| On April 28 2023 Bio Gene Technology was traded for 0.11 at the closing time. The maximum traded price for the trading interval was 0.11 and the lowest daily price was 0.11 . The daily volume was recorded at 82.5 K. The volume of trading on 28th of April 2023 played a part in the next trading day price appreciation. The overall trading delta to the next closing price was 14.58% . The overall trading delta to the closing price today is 35.42% . |
Bio Gene Technology Fundamentals Correlations and Trends
By evaluating Bio Gene's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bio Gene's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bio Gene Stock history
Bio Gene investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bio Gene Technology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bio Gene stock prices may prove useful in developing a viable investing in Bio Gene
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 185.8 M | 141.8 M | |
| Net Loss | -2.8 M | -2.6 M |
Bio Gene Quarterly Net Working Capital |
|
Bio Gene Stock Technical Analysis
Bio Gene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bio Gene Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Bio Gene Technology cannot be verified against its exchange. Please verify the symbol is currently traded on Australian Securities Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bio Gene December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Bio Gene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bio Gene shares will generate the highest return on investment. By undertsting and applying Bio Gene stock market strength indicators, traders can identify Bio Gene Technology entry and exit signals to maximize returns
Bio Gene Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bio Gene's price direction in advance. Along with the technical and fundamental analysis of Bio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.74) | |||
| Treynor Ratio | (0.17) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Bio Stock Analysis
When running Bio Gene's price analysis, check to measure Bio Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Gene is operating at the current time. Most of Bio Gene's value examination focuses on studying past and present price action to predict the probability of Bio Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Gene's price. Additionally, you may evaluate how the addition of Bio Gene to your portfolios can decrease your overall portfolio volatility.